Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

(2015) Stefan S. Bielack et al.   JOURNAL OF CLINICAL ONCOLOGY

IL-2: The First Effective Immunotherapy for Human Cancer

(2014) S. A. Rosenberg   JOURNAL OF IMMUNOLOGY

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis

(2013) Sergei R. Guma et al.   PEDIATRIC BLOOD & CANCER

High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: Final results of the ISG/SSG II study

(2013) Kjetil Boye et al.   PEDIATRIC BLOOD & CANCER

Outcome for adolescent and young adult patients with osteosarcoma

(2012) Katherine A. Janeway et al.   CANCER

Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma After Megatherapy and Autologous Stem-Cell Reinfusion

(2010) Ruth Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

(2009) Alexander J. Chou et al.   CANCER

High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005

(2009) Antonio Briccoli et al.   SURGICAL ONCOLOGY-OXFORD

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

(2008) Paul A. Meyers et al.   JOURNAL OF CLINICAL ONCOLOGY